Document is current
Any future updates will be listed below
-
Authors
Wan, Kim Sui
Mat Rifin, Halizah
Mohd Yusoff, Muhammad Fadhli
Chan, Wah Kheong
Yoga Ratnam, Kishwen Kanna
Ganapathy, Shubash Shander
Abd Hamid, Hamizatul Akmal
Mohamad, Masni
Mohd Noor, Nurain
Mustapha, Feisul
Ahmad, Noor Ani
-
Funding
Funding for this research was provided by:
Kementerian Kesihatan Malaysia (91000050)
- License Information
-
More Information
Article History
Received: 14 November 2024
Accepted: 4 December 2025
First Online: 14 January 2026
Declarations
:
: Wah-Kheong Chan served as a consultant or advisory board member for Abbott, Roche, AbbVie, Boehringer Ingelheim, and Novo Nordisk; and a speaker for Abbott, Novo Nordisk, Echosens, Viatris and Hisky Medical. Other authors have no conflict of interest.
